购物车 (0)

DIA会员及用户请点击登录

登录

忘记用户 ID？ or 忘记密码？

Not a Member?

创建账户并加入。

Bethesda North Marriott Hotel and Conference Center

2017 年 10 月 25 日 7:00 上午 - 2017 年 10 月 27 日 3:00 下午

5701 Marinelli Road, , North Bethesda, MD 20852 , USA

DIA/FDA Oligonucleotide-Based Therapeutics Conference

Convening industry and health authorities to inform, educate, and share advancements in oligonucleotide-based therapeutic product development.

返回 Agenda

Breakfast Plenary Session: Emergency Single Patient IND for Oligonucleotide Therapy of a Unique Individual Mutation: A Case Study in Batten's Disease

Session Chair(s)

Arthur M. Krieg, MD

Arthur M. Krieg, MD

CEO and CSO

Checkmate Pharmaceuticals, United States

Breakfast Plenary Session: Emergency Single Patient IND for Oligonucleotide Therapy of a Unique Individual Mutation: A Case Study in Batten's Disease

Speaker(s)

Timothy W. Yu, MD, PhD

Speaker

Timothy W. Yu, MD, PhD

Boston Children’s Hospital, United States

Associate Professor, Harvard Medical School; Division of Genetics and Genomics